Page 16 - Astrazeneca

AstraZeneca may have used outdated info in coronavirus vaccine trial: US

Results from a US trial of AstraZeneca's Covid-19 vaccine may have used "outdated information," US federal health officials said in a statement early Tuesday

Spain broadens use of AstraZeneca's Covid jab to adults under age of 65

Spain's health minister has said the country will resume the use of the AstraZeneca coronavirus vaccine on Wednesday by extending it to adults under the age of 65

AstraZeneca US trial shows 79% efficacy against Covid-19 pandemic

Trial found no increased risk of blood clots

One year on

Ravages of last year's lockdown may still affect economy

AstraZeneca says US trial data shows Covid-19 vaccine 79% effective

AstraZeneca says advanced trial data from a US study on its Covid-19 vaccine shows it is 79 per cent effective

Taiwan kicks off vaccination drive with AstraZeneca's shot against Covid

Health care workers received the first shots in Taiwan's Covid-19 vaccination drive, beginning a campaign that won't use supplies from China amid uneven distribution of the vaccines globally

South Africa confirms sale of unused Indian AstraZeneca vaccines finalised

South African Health Minister Zweli Mkhize has confirmed the sale of one million doses of the AstraZeneca coronavirus vaccine received from the Serum Institute of India last month has been concluded

Italian PM Draghi to be vaccinated with AstraZeneca Covid-19 vaccine

Italian Prime Minister Mario Draghi said he would be inoculated with the AstraZeneca vaccine against coronavirus

Finland suspends use of AstraZeneca vaccines after cases of blood clots

Finland on Friday suspended the use of Oxford-AstraZeneca Covid-19 vaccines after two cases of blood clots were reported in people after receiving the dose

Covid-19 pandemic: Keep using AstraZeneca vaccine, WHO urges world

"We urge countries to continue using this important Covid-19 vaccine," WHO Director General Tedros Adhanom Ghebreyesus told a news conference in Geneva.

EU resets AstraZeneca vaccine effort after chaos that may undermine trust

Countries across the European Union, including Germany, France and Spain, are resuming using AstraZeneca Plc's vaccine after temporarily suspending it to investigate a possible blood-clot issue

UK Prime Minister Boris Johnson gets his first dose of AstraZeneca vaccine

Johnson, 56, received his vaccine at the same hospital where almost a year ago he was put in an intensive care unit and given oxygen via a tube in his nose after he contracted the virus

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

AstraZeneca shots resumed after regulators say benefits outweigh risks

Oxford University is partnered with AstraZeneca on the vaccine

UK PM Boris Johnson to receive jab of AstraZeneca Covid-19 vaccine today

UK Prime Minister Boris Johnson on Thursday announced getting inoculated with the AstraZeneca vaccine on Friday

Spain, Cyprus, Italy, France to resume use of AstraZeneca Covid-19 vaccine

Spain, Cyprus, Italy and France will resume administering the Oxford-AstraZeneca Covid-19 vaccine, after the European Medicines Agency (EMA) said it was 'safe and effective'

Britain to slow coronavirus vaccine rollout due to supply crunch in India

Britain will have to slow its vaccine rollout next month due to a supply crunch caused by a delay in a shipment of AstraZeneca shots from India and the need to test the stability of 1.7 million doses

UK reports five cases of rare blood clots in 11 million AstraZeneca shots

Caccine is 'safe and effective' and benefits outweigh any risks, says EMA

Oil hits skids, drops 7% on worsening outlook for coronavirus in Europe

Several large European economies have had to reimpose lockdowns as caseloads rise, while vaccination programs are slowing due to concerns about side effects of the AstraZeneca vaccine

AstraZeneca coronavirus vaccine safe, will add clot warning: EU agency

Germany, France and others had said they wanted to wait for the European Medicines Agency's determination before deciding whether to resume using the vaccine